Baxter International Inc
BAX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| t@ | LOCK|^<^jM | LOCK|^<g |
Baxter Earnings: New Management Team Continues to Make Progress and Boosts 2026 Guidance
Baxter's third-quarter results included 5% organic revenue growth and adjusted EPS of $0.58, above FactSet consensus of $0.52. Management also raised its 2026 outlook, including organic sales growth to 3%-4%, up from 2%-3% previously, and adjusted EPS to $2.05-$2.15, up from $1.95-$2.15.
